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Abstract
Background—The prevalence and determinants of dyslipidemia patterns among Hispanics/
Latinos are not well known.
Methods—Lipid and lipoprotein data were used from the Hispanic Community Health Study / 
Study of Latinos -- a population-based cohort of 16,415 US Hispanic/Latinos ages 18–74. 
National Cholesterol Education Program cutoffs were employed. Differences in demographics, 
lifestyle factors, biological and acculturation characteristics were compared among those with and 
without dyslipidemia.
Results—Mean age was 41.1 years and 47.9% were male. The overall prevalence of any 
dyslipidemia was 65.0%. The prevalence of elevated LDL-C was 36.0% and highest among 
Cubans (44.5%; p<0.001). Low HDL-C was present in 41.4% and did not significantly differ 
across Hispanic background groups (p=0.09). High triglycerides were seen in 14.8% of Hispanics/
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Latinos, most commonly among Central Americans (18.3%; p<0.001). Elevated non-HDL-C was 
seen in 34.7% with the highest prevalence among Cubans (43.3%; p<0.001). Dominicans 
consistently had a lower prevalence of most types of dyslipidemia. In multivariate analyses, the 
presence of any dyslipidemia was associated with increasing age, body mass index and low 
physical activity. Older age, female gender, diabetes, low physical activity, and alcohol use were 
associated with specific dyslipidemia types. Spanish-language preference and lower educational 
status were associated with higher dyslipidemia prevalence.
Conclusion—Dyslipidemia is highly prevalent among US Hispanics/Latinos; Cubans seem 
particularly at risk. Determinants of dyslipidemia varied across Hispanic backgrounds with 
socioeconomic status and acculturation having a significant effect on dyslipidemia prevalence. 
This information can help guide public health measures to prevent disparities among the US 
Hispanic/Latino population.
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Cardiovascular disease remains the leading cause of death among Hispanics/Latinos in the 
United States (US),1 yet Hispanics/Latinos have been underrepresented in studies of 
cardiovascular disease risk factors, especially lipids, as well as clinical intervention trials.2 
In particular, determinants and prevalence estimates of dyslipidemia among Hispanics/
Latinos are not well known. Hispanic/Latino cohorts in prior studies have been relatively 
small, without appropriate representation of Hispanic/Latino background groups, lacked 
analysis by Hispanic/Latino background groups, and were not representative of / 
generalizable to the total Hispanic/Latino population.3–5 Furthermore, the full complement 
of plasma lipid and lipoprotein components were not examined in prior studies that only 
used total cholesterol (TC) or low-density lipoprotein cholesterol (LDL-C) levels to define 
dyslipidemia.
The Hispanic Community Health Study / Study of Latinos (HCHS-SOL) is the largest and 
most comprehensive study of US Hispanic/Latino adults conducted to date.6 HCHS-SOL is 
multi-centered and utilized a sampling design that ensured enrollment from all the various 
Hispanic national/ethnic background groups7 including a full complement of plasma lipids 
and lipoproteins measurements.
The current analyses examined the prevalence of each dyslipidemia type among the HCHS-
SOL target population; evaluated whether any of the above prevalence estimates differed by 
Hispanic background group; and compared differences in demographic and lifestyle factors, 
biological and cultural characteristics, acculturation and socioeconomic factors between 
those with normal and abnormal lipid and lipoprotein components.
Methods
The HCHS/SOL is a population-based study designed to examine risk and protective factors 
for chronic diseases and to quantify morbidity and mortality prospectively. Details of the 
sampling methods and design have been published.6, 7 The HCHS/SOL examined 16,415 
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self-identified Hispanic/Latino persons (9,835 women and 6,580 men) aged 18–74 years at 
the time of screening, recruited from selected households in 4 US communities (Bronx, New 
York; Chicago, Illinois; Miami, Florida; San Diego, California) using a stratified 2-stage 
area probability sample design. Census block groups were randomly selected in the defined 
community areas of each field center, and households were randomly selected in each 
sampled block group. Sampling weights were established based on the probably of selection, 
adjustment for non-response, trimming to handle extreme values of the weights, calibration 
to the known population distribution, and normalized to the entire HCHS/SOL target 
population. The HCHS/SOL included participants from Cuban, Dominican, Mexican, Puerto 
Rican, Central American, and South American backgrounds (according to self-reported 
national/ethnic heritage). All HCHS-SOL participants with lipid components analyzed at 
baseline (n = 16,207) were included in this analysis. This study was approved by the local 
institutional review board at each of the field centers and all participants gave informed 
patient consent prior to enrollment.
Lipid variables
Blood lipids and lipoproteins were measured on samples obtained after an overnight fast. 
Specimens were stored at −20°C and shipped we ekly to the Lipoprotein Analytical 
Laboratory at the HCHS/SOL Central Lab at the University of Minnesota Medical Center. 
This laboratory participates in the Lipid Standardization Program of the Centers for Disease 
Control and Prevention. Serum TC was measured using a cholesterol oxidase enzymatic 
method, triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C) levels were 
measured with a direct magnesium/dextran sulfate method. TG levels were measured in 
EDTA plasma with the use of TG GB reagent (Roche Diagnostics) on a Roche centrifugal 
analyzer. LDL-C was calculated using the Friedewald equation.8 Non-HDL-C was 
calculated by subtracting the HDL-C level from TC. Different patterns of dyslipidemia were 
defined based on National Cholesterol Education Program / Adult Treatment Panel III 
(NCEP/ATP III) guidelines as follows: LDL-C > 130 mg/dl, TG > 200 mg/dl, non-HDL-C > 
160 mg/dl, TC > 240 mg/dl, and low HDL-C (< 40 mg/dl for men and < 50 mg/dl for 
women)9, 10 Mixed dyslipidemia was defined by the presence of both elevated TG levels 
and low HDL-C, reflecting an increased cardiovascular risk irrespective of LDL-C 
levels.11, 12 ‘Any dyslipidemia’ was a variable reflective of having one or more of any of 
these dyslipidemia patterns.
Demographic and Clinical variables
Demographic questionnaires and medical history form were administered by trained and 
certified staff. Trained and certified clinic staff obtained blood samples and anthropometric 
and blood pressure measurements. Medication use was obtained using a questionnaire. 
Additionally, an inventory of both medications and supplements used during the last four 
weeks were also reviewed and coded. Alcohol use was captured as data on lifetime use, 
current use, and former use of alcohol. Physical activity was based on the commonly used 
Global Physical Activity Questionnaire (GPAQ) which captures self-report of low, 
moderate, and high energy expenditure activities both at work and during leisure time. 
Diabetes was defined based on American Diabetes Association definition13 using one or 
more of the following criteria: fasting serum glucose ≥126 mg/dl; oral glucose tolerance test 
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≥200 mg/dl; self-reported diabetes, A1C percentages ≥6.5 or taking anti-diabetic medication 
or insulin. Height was measured to the nearest 0.1 cm and weight was measured to the 
nearest 0.1 kilogram with the use of a balanced scale. Body mass index (BMI) was 
calculated as weight in kilograms divided by height in meters squared. After a 5-minute rest, 
blood pressure was measured three times at one-minute intervals using an automated 
oscillometric device in a seated position with the back and arm supported.14 All available 
blood pressure measurements were averaged. Ninety-nine percent of participants had all 
three measures. Hypertension was defined as a systolic blood pressure of 140 mmHg or 
higher, diastolic blood pressure of 90 mmHg or higher or on antihypertensive treatment.
Socioeconomic and Acculturation assessment
Socioeconomic position was assessed using years of educational attainment defined as 
highest degree or level of school completed and household income level, each classified into 
groups (less than high school; completed high school or high school equivalent; and 
attainment of education beyond high school) and (<$20,000; $20,000 to $39,999; $40,000 to 
$75,000 and >$75,000) respectively. Acculturation was defined using multiple proxy 
indicators, including nativity, duration of residence in the US, and language preference 
(English vs. Spanish). Greater years of residence in the US and English-language preference 
indicating higher levels of acculturation.
Statistical analysis
Demographic factors, anthropometric measurements, lifestyle factors, and biological profiles 
were compared in those with abnormal vs. normal lipid components. Continuous variables 
were compared using regression analysis for sample survey data and categorical variables 
were compared using Rao-Scott chi-square. Associations across Hispanic background 
groups for each dyslipidemia pattern was tested using Rao-Scott chi-square15 and regression 
analyses for sample survey for categorical and continuous variables, respectively. Chi-
square tests were used to examine whether the prevalence of each dyslipidemia pattern 
varied significantly across categories of SES or acculturation. Multivariate logistic 
regression analyses were conducted with all of the dyslipidemia correlates entered into the 
model simultaneously, so that the unique influence of each given correlate could be 
examined. All analyses were conducted using SAS survey procedure (SAS 9.3) and were 
weighted to adjust for sampling probability and non-response, in accordance with guidelines 
suggested by the HCHS-SOL Steering and Data Analysis Committees to make the estimates 
applicable to the target population from which the HCHS/SOL sample was drawn. In 
supplemental analysis, we examined TC/HDL-C and LDL-C/HDL-C ratios as continuous 
variables and as binary variables using established abnormal cutoffs of ≥3.5 and ≤0.4, 
respectively.
Results
Description of the target population
Overall, diabetes was prevalent in almost 15% of the target population while obesity 
prevalence approached 40%. Over half were current alcohol drinkers and about one-fifth 
were current smokers. Mean LDL-C levels were 119.7 mg/dl, TG 133.4 mg/dl, TC 194.3 
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mg/dl, and HDL-C 48.5 mg/dl; all within normal limits. Only 9.2% of the population was on 
lipid-lowering drugs.
Dyslipidemia in the target population and across Hispanic background groups
Almost two-thirds of Hispanics/Latinos had some form of dyslipidemia. Those with any 
dyslipidemia were significantly older, more likely to be female, more likely to have 
hypertension and diabetes, more likely to be obese and have low levels of physical activity 
and were less likely to drink any alcohol. (Table 1) Overall a slightly higher but significant 
proportion of women had any dyslipidemia compared to men (p<0.01). However, the 
distribution of specific dyslipidemia patterns varied by gender. Hispanic/Latino women had 
a particularly higher prevalence of low HDL-C compared to men (p<0.01); whereas 
Hispanic men had a higher prevalence of high LDL-C, high TG, high non-HDL-C levels, 
and mixed dyslipidemia compared to women (all p<0.01). In general, the various patterns of 
dyslipidemia were consistently less prevalent among the younger age group, then peaked in 
the 45–54 year age group and declined somewhat in the 65+ age group. In contrast, low 
HDL-C was most prevalent among younger Hispanics/Latinos compared to the other age 
groups (all p<0.01). (Figures 1a, 1b)
In Table 2, the prevalence of any dyslipidemia was lowest among Dominicans and highest 
among Central Americans and Cubans. Elevated LDL-C was prevalent in over one-third of 
all Hispanics/Latinos, and highest among Cubans. Low HDL-C was present in 41% of the 
population overall; Puerto Ricans had the highest prevalence of low HDL-C dyslipidemia 
but not significantly different from other groups. High TGs were seen in 15% overall, most 
commonly among Central Americans. Elevated non-HDL-C was present in over one-third of 
the sample, with rates significantly higher among Cubans compared to all other groups. 
Prevalence rates of all four types of dyslipidemia were consistently highest among Cubans 
and lowest among Dominicans.
Figure 2 examines factors independently associated with some form of dyslipidemia. 
Overall, increasing age, female gender, higher BMI, low physical activity were all 
associated with Hispanics/Latinos having some form of dyslipidemia, while current alcohol 
use was associated with a lower odds of having any dyslipidemia. Higher age was associated 
with a significantly lower prevalence of low HDL but a higher prevalence of other 
dyslipidemia types. Female gender was associated with higher prevalence of low HDL-C but 
a lower prevalence of elevated TGs, non-HDL-C or LDL-C. Those with low prevalence of 
dyslipidemia patterns tended to be hypertensive. Diabetes was associated with a lower 
prevalence of high LDL but a higher prevalence of low HDL and high TG. Low physical 
activity was significantly associated with elevated TGs and low HDL-C. Current alcohol use 
was independently associated with a significantly lower prevalence of low HDL-C but not 
associated with other dyslipidemia types.
There were few differences across the Hispanic background groups with regards to 
correlates of dyslipidemia. BMI was consistently associated with dyslipidemia prevalence 
across all groups. Age was more strongly associated with higher prevalence of any 
dyslipidemia among Puerto Ricans; whereas female gender was a stronger correlate of 
higher prevalence of any dyslipidemia among Puerto Ricans compared to the other groups. 
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Low PA and hypertension prevalence appeared to be more relevant among Puerto Ricans, 
being associated with significantly higher and lower odds of any dyslipidemia, respectively, 
among Puerto Ricans but not among the other groups. (Supplemental Figure)
Almost two-thirds and almost half of the population had abnormal LDL-C/HDL-C and TC/
HDL-C ratios, respectively. Abnormal TC/HDL-C ratios were found most frequently among 
Central Americans and Cubans; less so among Dominicans (p<0.001). Abnormal LDL-C/
HDL-C ratios were seen most frequently among Cubans and less so among Dominicans and 
Puerto Ricans (p<0.001). (Supplemental Table)
SES and acculturation
In the HCHS-SOL target population, the duration of residence in the US was not 
significantly associated with dyslipidemia prevalence. English-language preference was 
associated with lower prevalence of dyslipidemia compared to Spanish speakers, with 
findings consistent for every dyslipidemia type except low HDL-C which was consistently 
high regardless of language preference. Lower income was associated with higher 
prevalence of any dyslipidemia but most specifically for high TGs and low HDL-C. Among 
Hispanics/Latinos with higher educational attainment, prevalence rates of any dyslipidemia 
were significantly lower compared to those with lower levels of educational attainment 
regardless of the type of dyslipidemia. (Table 3)
Discussion
Dyslipidemia when defined comprehensively according to the NECP/ATP III guidelines,9 is 
highly prevalent among Hispanics/Latinos with almost 2/3 of the HCHS-SOL population 
exhibiting some form of dyslipidemia, particularly beyond the age of 40. Low HDL-C and 
elevated LDL-C were the most common types of dyslipidemia seen among Hispanics/
Latinos. We found the overall prevalence of any dyslipidemia to be slightly higher among 
women compared to men, but this varied depending on the specific dyslipidemia type, with 
women more likely to have low HDL-C and men more likely to have high LDL-C, high TG, 
and high non-HDL-C. Except for low HDL-C, the prevalence of dyslipidemia increased 
with age, peaking at ages 45–64, and tapering off somewhat in those aged 65 to 74 years.
Few studies have systematically examined differences in lipid profiles across different 
Hispanic groups. One study among 928 ischemic stroke patients,16 found significant 
differences in lipid fractions, with lower LDL-C levels and higher TG levels in Mexicans 
compared to Caribbean-Hispanics (Dominicans, Cubans, Puerto Ricans) highlighting the 
potential heterogeneity of dyslipidemia among the Hispanic groups. To our knowledge, our 
study is the first to compare dyslipidemia among a broad range of Hispanic/Latino adults 
with a full complement of lipid and lipoprotein fractions. Our data show that although 
dyslipidemia prevalence rates were high across all Hispanic/Latinos, some groups fared 
worse than others. Individuals of Cuban and Central American descent seem particularly at 
risk. Those of Dominican descent seem at the lowest risk relative to other Hispanics/Latinos. 
The prevalence of elevated LDL-C and elevated non-HDL-C were highest among Cubans. 
Central Americans had the highest prevalence of high TGs. The prevalence of low HDL-C 
did not vary significantly across the groups. We found a high prevalence of abnormal TC-
Rodriguez et al. Page 6













HDL-C ratios in the overall Hispanic/Latino population, particularly in Cubans and Central 
Americans, possibly reflecting an increased presence of small, dense LDL-C and other 
atherogenic apoB-containing particles.17 However, at this time, it is generally believed that 
cholesterol ratios do not provide additional prognostic information beyond the absolute 
cholesterol numbers when planning treatment.18
Our estimates of dyslipidemia are higher compared to those reported in other population-
based studies such as the National Health and Nutrition Examination Survey 
(NHANES).1, 19 A meaningful comparison is difficult however, because of differences in 
time periods when prior studies were conducted, different study populations (Mexican-only 
or incomplete inclusion of Hispanic background groups), examination Hispanics/Latinos 
only as an aggregate single group and different and less rigorous definitions for dyslipidemia 
(total cholesterol only vs. the more comprehensive NCEP/ATP III definitions).
In the Minnesota Heart Survey, among mostly non-Hispanic whites, the mean prevalence of 
hypercholesterolemia (defined by TC >240mg/dl or use of antihyperlipidemics) was 23.9% 
for men and 17.3% for women.20 Data from NHANES 2007-10, the prevalence of 
hypercholesterolemia (defined by TC >240mg/dl) was 12.3% and 15.6% for non-Hispanic 
white men and women; 10.8% and 11.7% for non-Hispanic black men and women, 
respectively.21 For the Multi-Ethnic Study of Atherosclerosis (MESA), the prevalence of 
dyslipidemia (defined by abnormal LDL-C) was 19.7% and 8.4% for non-Hispanic white 
men and women; 18.2% and 14.0% for non-Hispanic black men and women, respectively.22 
The Genetic Epidemiology Network of Arteriopathy study showed dyslipidemia prevalence 
(defined by abnormal LDL-C, HDL-C or TG) was greater among non-Hispanic whites than 
non-Hispanic blacks (women, 64.7% vs 49.5%; men, 78.4% vs 56.7%).23 Our higher 
prevalence of overall dyslipidemia and specific dyslipidemia types in our population of 
Hispanics/Latinos compared to published estimates among non-Hispanic whites and blacks 
is concerning and highlights persistent disparities as well as invalidating the prior notion of 
Hispanics/Latinos as a lower (or similar) risk group compared to non-Hispanic whites.
According to 2005-08 NHANES data, Mexican American men and women age 20 and 
older, 16.9% and 14.0%, respectively had total cholesterol levels ≥240 mg/dL and 42% and 
32% had LDL-C levels ≥130mg/dL.1 Data from the 1982-84 Hispanic Health and Nutrition 
Examination Survey demonstrate variation in hypercholesterolemia prevalence between 
three Hispanic background groups—Mexicans, Cubans, and Puerto Ricans. However, 
women had the highest prevalence of hypercholesterolemia, with Puerto Ricans women 
having a prevalence of 20.6%.19 According to updated AHA statistics based on 2010 
NHANES data,1 15.2% of Mexican men and 13.5% of Mexican women have TC levels 
≥240mg/dL; 39.9% of men and 30.4% of women had LDL levels ≥130mg/dL; 34.2% of 
men and 15.1% of women had HDL-C levels less than 40mg/dL. When comparing these 
patterns to those observed in the HCHS-SOL target population, among Mexicans, the 
prevalence of elevated TC and LDL-C was only slightly lower in HCHS-SOL; however the 
prevalence of low HDL-C is significantly higher among the HCHS-SOL target population 
and worse among women, possibly due to the fact that gender-specific cutoffs for low HDL-
C were used in our analysis.
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Hispanics/Latinos residing in the US are not monolithic. They have variations in dietary 
patterns, different genetic racial ancestries, differential immigration patterns that may 
influence dyslipidemia. Ethnic differences in dietary intake have been shown to be 
associated with serum lipid levels in Hispanics/Latinos.24 As a group, Hispanics/Latinos 
face substantial socioeconomic adversity25 and poor healthcare access.25 In addition, 
Hispanics/Latinos often reside in unhealthy built environments26 that foster environmental 
and social risk factors such as lack of access to healthy foods, lack of places to walk and 
exercise, and poor access to primary care that can impact dyslipidemia prevalence. It is well 
known that race influences serum lipids. Studies have reported racial/ethnic variation in 
blood lipid levels, with lower TG and higher HDL-C among African Americans than in 
persons of European descent.27, 28 Interestingly, differences seem to exist between the 
genetic determinants of lipid profiles in African Americans and European Americans.29 It is 
possible that significant variation in the levels of African ancestry, Amerindian, and 
European ancestry across the diverse Hispanic/Latino background groups30 influenced 
serum lipid concentrations and dyslipidemia prevalence.
Of note, a lower prevalence of dyslipidemia was seen among Dominican-origin Hispanics/
Latinos – a finding that persisted for most types of dyslipidemia. Not much has been 
published about Hispanics of Dominican background, who account for ∼3% of US 
Hispanics/Latinos. The Dominican community is primarily composed of more recent 
immigrants over the last 30–40 years.31 Their more recent immigration and possible 
increased retainment of traditional cultural values and norms may contribute to the observed 
trend in dyslipidemia. Another possibility is that there may be greater African ancestry in 
Dominican-origin Hispanics/Latinos,32 thus a greater likelihood for a healthier lipid profile 
with lower TG and higher HDL-C.
Socioeconomic status and acculturation were significantly related to dyslipidemia across all 
Hispanics/Latinos. Lower educational attainment and Spanish-language preference were 
consistent correlates of dyslipidemia prevalence. There have been few reports examining the 
cross-sectional relationships between acculturation measures and lipoprotein levels among 
Hispanics/Latinos. The MESA showed that Spanish-language preference Hispanics/Latinos 
and those who had lived a longer proportion of life in the US had significantly higher LDL-
C than English-language preference Hispanics/Latinos and those who had fewer years in the 
US.33 Our findings suggest that dyslipidemia prevalence among Hispanic/Latino individuals 
is reduced by English-language preference and increasing educational attainment possibly 
because of the acquisition of skills required to navigate the healthcare system. Thus, the 
relationship between greater acculturation and lower prevalence of dyslipidemia may be 
largely driven by higher rates of diagnosis and more accessible treatment.
Study Strengths and Limitations
The strengths of this study include its population-based sampling frame and the availability 
of comprehensive lipid and lipoprotein measurements to determine undiagnosed and 
diagnosed dyslipidemia prevalence and NCEP / ATP III goal attainment. A limitation is that 
given our focus on the specific dyslipidemia types, dyslipidemia prevalence needed to be 
based on actual measured serum lipid and lipoprotein levels and not on lipid-lowering 
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medication use. Thus, it is likely that any dyslipidemia prevalence is actually underestimated 
in our study. Our study is also limited by its descriptive and cross-sectional nature thus 
precluding any inferences of causality. The HCHS/SOL is a multisite study representative of 
specific US geographic areas and is not nationally representative. Inferences beyond these 
regions may not be fully appropriate.
In conclusion, the US Hispanic/Latino population has a high prevalence of dyslipidemia. 
Certain specific groups defined by country of heritage, sociodemographic or sociocultural 
characteristics are disproportionately affected. These findings can hopefully inform and 
contribute to the development of effective and comprehensive public health strategies that 
improve the cardiovascular health of Hispanics/Latinos in the US.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Dyslipidemia is highly prevalent among all US Hispanics/Latinos; Cubans are at 
particularly high risk.
• Determinants of dyslipidemia varied across Hispanic backgrounds; measures of 
socioeconomic status and acculturation were significantly related to 
dyslipidemia prevalence.
• This information can help guide public health measures and can be useful in 
efforts to eliminate cardiovascular risk factor disparities in the US Hispanic/
Latino population.
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Correlates of Dyslipidemia Patterns for All Hispanics
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